Evidence map›Paper›PMID 34001963›Full record

ArticleScientific reports2021

TERTp mutations and p53 expression in head and neck cutaneous basal cell carcinomas with different aggressive features.

António Castanheira, Maria João Vieira, Mafalda Pinto, Carolina Dias, Luísa Prada, Sofia Macedo, Margarida Sá Fernandes, Fortunato Vieira, Paula Soares, Alberto Mota and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

António Castanheira *Department of Otorhinolaryngology, Centro Hospitalar de Trás-Os-Montes e Alto Douro, Vila Real, Portugal.
Maria João Vieira *IPATIMUP-Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal.
Mafalda Pinto *IPATIMUP-Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal.
Carolina DiasIPATIMUP-Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal.
Luísa PradaIPATIMUP-Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal.
Sofia MacedoIPATIMUP-Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal.
Margarida Sá FernandesDepartment of Pathology, Centro Hospitalar São João, Porto, Portugal.
Fortunato VieiraHISTOCIT - Laboratório de Anatomia Patológica, Trofa, Portugal.
Paula SoaresFMUP-Faculty of Medicine, University of Porto, Porto, Portugal.
Alberto MotaFMUP-Faculty of Medicine, University of Porto, Porto, Portugal.
José Manuel LopesFMUP-Faculty of Medicine, University of Porto, Porto, Portugal.
Paula BoaventuraFMUP-Faculty of Medicine, University of Porto, Porto, Portugal. mboaventura@ipatimup.pt.
Universidade do Porto · PTAnthrologica · GBCentro Hospitalar do Porto · PTUniversity of Lisbon · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cutaneous basal cell carcinoma (cBCC) is an economic burden to health services, due to its great morbidity and increasing incidence in old people. Infiltrative cBCCs and cBCCs with micronodular pattern are considered as more aggressive. The role of p53 expression and TERTp mutation on cBCC behavior remains to be clarified. We aimed to assess TERTp mutations and p53 expression in relation to the cBCC histological subtype in a cohort of patients referred to an ENT Department of a tertiary Hospital of Northern Portugal. We performed a retrospective clinicopathological and histological review of the head and neck cBCCs followed-up at the otorhinolaryngology department of Trás-os-Montes e Alto Douro hospital (January 2007-June 2018). We assessed TERTp mutations in 142 cBCCs and p53 protein expression, through immunohistochemistry, in 157 cBCCs. We detected TERTp mutations in 43.7% of cBCCs and p53 overexpression in 60.5% of cBCCs. We spotted association of p53 overexpression and TERTp mutation with necrosis. In the infitrative-growth pattern cBCCs, there was no significant association with the clinical and histological features evaluated, except for necrosis. In the indolent-growth cBCCs, we identified a significant association of TERTp mutation status with female sex, necrosis, multiple cBCCs, and p53 positive expression. Our results suggest that TERTp mutation may be useful to identify more aggressive features in the indolent-growth pattern cBCCs (nodular and superficial subtypes). Further studies with larger cohorts are warranted to clarify the relevance of TERTp mutation in cBCCs.

Indexed as

AgedBasal Cell CarcinomaFemaleGene Expression Regulation, NeoplasticHead and Neck NeoplasmsHumansMaleMutationPromoter Regions, GeneticSkin NeoplasmsTelomeraseTumor Suppressor Protein p53TelomeraseTERT protein, humanTP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID34001963
PMCPMC8129122
OpenAlexW3161927142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.